One study of lung cancer demonstrated that PDCD6 overexpression was indicative of unfavorable prognosis for patients with early stage non-small cell lung cancer or lung adenocarcinoma; the protein may serve as a potential molecular marker for aggressive lung cancer [23]. The gene discussed is PDCD6; the disease is lung carcinoma.